References
- Pattni S, Walters JR. Recent advances in the understanding of bile acid malabsorption. Br. Med. Bull.92, 79–93 (2009).
- Maneerattanaporn M, Chang L, Chey WD. Emerging pharmacological therapies for the irritable bowel syndrome. Gastroenterol. Clin. North Am.40(1), 223–243 (2011).
- Bajor A, Gillberg PG, Abrahamsson H. Bile acids: short and long term effects in the intestine. Scand. J. Gastroenterol.45(6), 645–664 (2010).
- Bampton PA, Dinning PG, Kennedy ML, Lubowski DZ, Cook IJ. The proximal colonic motor response to rectal mechanical and chemical stimulation. Am. J. Physiol. Gastrointest. Liver Physiol.282(3), G443–G449 (2002).
- Edwards CA, Brown S, Baxter AJ, Bannister JJ, Read NW. Effect of bile acid on anorectal function in man. Gut30(3), 383–386 (1989).
- Kirwan WO, Smith AN, Mitchell WD, Falconer JD, Eastwood MA. Bile acids and colonic motility in the rabbit and the human. Gut16(11), 894–902 (1975).
- Odunsi ST, Camilleri M, Busciglio I et al. Effects of chenodeoxycholic acid on gastrointestinal and colonic transit and bowel function in healthy volunteers. Gastroenterology136, A-531 (2009).
- Dinning PG, Bampton PA, Kennedy ML, Lubowski DZ, King D, Cook IJ. Impaired proximal colonic motor response to rectal mechanical and chemical stimulation in obstructed defecation. Dis. Colon Rectum48(9), 1777–1784 (2005).
- Hofmann AF, Loening-Baucke V, Lavine JE et al. Altered bile acid metabolism in childhood functional constipation: inactivation of secretory bile acids by sulfation in a subset of patients. J. Pediatr. Gastroenterol. Nutr.47(5), 598–606 (2008).
- Abrahamsson H, Ostlund-Lindqvist AM, Nilsson R, Simren M, Gillberg PG. Altered bile acid metabolism in patients with constipation-predominant irritable bowel syndrome and functional constipation. Scand. J. Gastroenterol.43(12), 1483–1488 (2008).
- Odunsi-Shiyanbade ST, Camilleri M, Mckinzie S et al. Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function. Clin. Gastroenterol. Hepatol.8(2), 159–165 (2010).
- Rao AS, Wong BS, Camilleri M et al. Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis. Gastroenterology139(5), 1549–1558 (2010).
- Simren M, Bajor A, Gillberg PG, Rudling M, Abrahamsson H. Randomised clinical trial: the ileal bile acid transporter inhibitor A3309 vs. placebo in patients with chronic idiopathic constipation – a double-blind study. Aliment. Pharmacol. Ther.34(1), 41–50 (2011).
- Wong BS, Camilleri M, Mckinzie S, Burton D, Graffner H, Zinsmeister A. Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in patients with functional constipation. Gastroenterology140(5 Suppl. 1), S146–S147 (2011).
- Chey WD, Camilleri M, Chang L, Rikner L, Graffner H. A randomized placebo-controlled Phase IIb trial of A3309, a bile acid transporter inhibitor, for chronic idiopathic constipation. Am. J. Gastroenterol. DOI: 10.1038/ajg.2011.162 (2011) (Epub ahead of print).